| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |